Improving surgical care for kidney tumors using digital tools
Optimization of the Surgical Care Pathway for Kidney Tumors by Digitizing Perioperative Nursing Coordination
This study is testing a new digital tool to see if it can improve care and support for patients having surgery for kidney tumors.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 1307 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Hospital, Bordeaux Academic / other |
| Locations | 11 sites (Angers and 10 other locations) |
| Trial ID | NCT06047600 on ClinicalTrials.gov |
What this trial studies
This project aims to enhance the perioperative care pathway for patients undergoing nephrectomy for kidney tumors by implementing the UroConnect remote monitoring device. The study will evaluate how this digital tool can optimize nursing coordination and patient support across multiple French medical centers. By formalizing the role of nurse coordinators and utilizing digital interfaces for patient education and self-assessment, the project seeks to improve the overall quality of care and streamline the surgical process. The impact on patients, caregivers, and the healthcare system will be assessed through this innovative approach.
Who should consider this trial
Good fit: Ideal candidates include patients scheduled for total or partial nephrectomy for kidney tumors who are affiliated with the French social security system.
Not a fit: Patients who may not benefit include those who do not speak French, are under guardianship, are pregnant at the time of surgery, or lack internet access.
Why it matters
Potential benefit: If successful, this initiative could significantly improve the quality of care and patient experience for those undergoing surgery for kidney tumors.
How similar studies have performed: While the use of digital tools in surgical care is gaining traction, this specific approach to coordinating perioperative care for kidney tumors is relatively novel and has not been extensively tested in previous studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Planned surgical management by total or partial nephrectomy for kidney tumor, * Affiliation or beneficiary of the French social security * Expressed consent for integration of the UroCCR cohort, * Expressed consent to participate in the DiPRU study. Exclusion Criteria: * Difficulties understanding and expressing oneself in French * Participant under guardianship or curatorship * Pregnancy at the time of surgery * No internet access
Where this trial is running
Angers and 10 other locations
- CHU d'Angers — Angers, France (Recruiting)
- CHU de Bordeaux — Bordeaux, France (Recruiting)
- Centre Catalan d'Urologie — Cabestany, France (Recruiting)
- CHU de Caen — Caen, France (Recruiting)
- Hôpital Henri Mondor — Créteil, France (Recruiting)
- Aphm — Marseille, France (Recruiting)
- CH de Mont de Marsan — Mont-de-Marsan, France (Recruiting)
- CHU de Nantes — Nantes, France (Recruiting)
- CHU de Nîmes — Nîmes, France (Recruiting)
- CHU de Strasbourg — Strasbourg, France (Recruiting)
- CHu de Toulouse — Toulouse, France (Recruiting)
Study contacts
- Study coordinator: Jean-Christophe Bernhard, MD, PhD
- Email: Jean-christophe.bernhard@chu-bordeaux.fr
- Phone: 05.57.82.06.87
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.